{"id":"https://openalex.org/W4362533849","doi":"https://doi.org/10.1158/1535-7163.22499139","title":"Supplementary Table 1 from A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity","display_name":"Supplementary Table 1 from A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362533849","doi":"https://doi.org/10.1158/1535-7163.22499139"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22499139","doi":"https://doi.org/10.1158/1535-7163.22499139","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22499139","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Recombinant_Immunotoxin_against_the_Tumor-Associated_Antigen_Mesothelin_Reengineered_for_High_Activity_Low_Off-Target_Toxicity_and_Reduced_Antigenicity/22499139/1/files/39957522.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Recombinant_Immunotoxin_against_the_Tumor-Associated_Antigen_Mesothelin_Reengineered_for_High_Activity_Low_Off-Target_Toxicity_and_Reduced_Antigenicity/22499139/1/files/39957522.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005963576","display_name":"John E. Weldon","orcid":"https://orcid.org/0000-0002-6516-9064","observed_orcids":["https://orcid.org/0000-0002-6516-9064"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John E. Weldon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110255289","display_name":"Laiman Xiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laiman Xiang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100677413","display_name":"Jingli Zhang","orcid":"https://orcid.org/0000-0002-8590-5233","observed_orcids":["https://orcid.org/0000-0002-8590-5233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingli Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111717418","display_name":"Richard Beers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Beers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087302369","display_name":"Dawn A. Walker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dawn A. Walker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086855365","display_name":"Masanori Onda","orcid":"https://orcid.org/0000-0002-6805-2152","observed_orcids":["https://orcid.org/0000-0002-6805-2152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masanori Onda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029872582","display_name":"Raffit Hassan","orcid":"https://orcid.org/0000-0002-4012-3633","observed_orcids":["https://orcid.org/0000-0002-4012-3633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raffit Hassan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-immunotoxin","display_name":"recombinant immunotoxin","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.9750000238418579},{"id":"https://openalex.org/keywords/in-vitro-cytotoxicity","display_name":"in vitro cytotoxicity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.9049999713897705},{"id":"https://openalex.org/keywords/antigenicity-reduction","display_name":"antigenicity reduction","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.9579718708992004},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.801066517829895},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.7695898413658142},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6521764993667603},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6445865631103516},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6327022314071655},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5359063744544983},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4887523651123047},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.394179105758667},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3488379120826721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2327868938446045},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18523138761520386},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1119026243686676},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09307345747947693},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22499139","doi":"https://doi.org/10.1158/1535-7163.22499139","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22499139","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Recombinant_Immunotoxin_against_the_Tumor-Associated_Antigen_Mesothelin_Reengineered_for_High_Activity_Low_Off-Target_Toxicity_and_Reduced_Antigenicity/22499139/1/files/39957522.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22499139.v1","doi":"https://doi.org/10.1158/1535-7163.22499139.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22499139.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22499139","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Recombinant_Immunotoxin_against_the_Tumor-Associated_Antigen_Mesothelin_Reengineered_for_High_Activity_Low_Off-Target_Toxicity_and_Reduced_Antigenicity/22499139","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22499139","doi":"https://doi.org/10.1158/1535-7163.22499139","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22499139","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Recombinant_Immunotoxin_against_the_Tumor-Associated_Antigen_Mesothelin_Reengineered_for_High_Activity_Low_Off-Target_Toxicity_and_Reduced_Antigenicity/22499139/1/files/39957522.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362533849.pdf","grobid_xml":"https://content.openalex.org/works/W4362533849.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362492615","https://openalex.org/W2132214488","https://openalex.org/W4392681772","https://openalex.org/W2175610656","https://openalex.org/W2345374388","https://openalex.org/W4362638121","https://openalex.org/W4362624998","https://openalex.org/W4362638274","https://openalex.org/W4308399419","https://openalex.org/W2739538304"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"71K,":[3],"In":[4],"vitro":[5],"cytotoxicity":[6],"summary":[7]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}